Anti-TNF therapy in Crohn's disease

SO Adegbola, K Sahnan, J Warusavitarne… - International journal of …, 2018 - mdpi.com
Crohn's disease (CD) accounts for a variety of clinical manifestations or phenotypes that
stem from chronic inflammation in the gastrointestinal tract. Its worldwide incidence is …

The Toronto consensus statements for the management of inflammatory bowel disease in pregnancy

GC Nguyen, CH Seow, C Maxwell, V Huang, Y Leung… - Gastroenterology, 2016 - Elsevier
Background & Aims The management of inflammatory bowel disease (IBD) poses a
particular challenge during pregnancy because the health of both the mother and the fetus …

2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

V Furer, C Rondaan, MW Heijstek… - Annals of the …, 2020 - ard.bmj.com
To update the European League Against Rheumatism (EULAR) recommendations for
vaccination in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD) …

Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study

X Mariette, F Förger, B Abraham, AD Flynn… - Annals of the …, 2018 - ard.bmj.com
Objectives There is a need for effective and safe treatment during pregnancy in women with
chronic inflammatory diseases. This study evaluated placental transfer of certolizumab pegol …

Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

JF Rahier, F Magro, C Abreu, A Armuzzi… - Journal of Crohn's …, 2014 - academic.oup.com
6.1. Background The incidence of tuberculosis (TB) is a concern at the start of the third
millennium, particularly with the increase of multiresistant (MDR-TB) and extended resistant …

BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding—Part I: standard and biologic disease modifying anti-rheumatic drugs and …

J Flint, S Panchal, A Hurrell, M van de Venne… - …, 2016 - academic.oup.com
Julia Flint1, Sonia Panchal2, Alice Hurrell3, Maud van de Venne4, Mary Gayed5, Karen
Schreiber6, 7, Subha Arthanari8, Joel Cunningham3, Lucy Flanders3, Louise Moore9, Amy …

Japanese guidelines for the management and treatment of generalized pustular psoriasis: the new pathogenesis and treatment of GPP

H Fujita, T Terui, K Hayama, M Akiyama… - The Journal of …, 2018 - Wiley Online Library
Generalized pustular psoriasis (GPP) is a rare disease characterized by recurrent fever and
systemic flushing accompanied by extensive sterile pustules. The committee of the …

Concentrations of adalimumab and infliximab in mothers and newborns, and effects on infection

M Julsgaard, LA Christensen, PR Gibson, RB Gearry… - Gastroenterology, 2016 - Elsevier
Background & Aims Little is known about in utero exposure to and postnatal clearance of
anti–tumor necrosis factor (anti-TNF) agents in neonates. We investigated the …

Psoriasis: which therapy for which patient: focus on special populations and chronic infections

SB Kaushik, MG Lebwohl - Journal of the American Academy of …, 2019 - Elsevier
Despite the availability of several new systemic agents for psoriasis treatment, choosing the
right therapy in certain patient populations can be challenging. There are few up-to-date …

[HTML][HTML] Crohn's disease

DC Baumgart, WJ Sandborn - The Lancet, 2012 - thelancet.com
Crohn's disease is a relapsing systemic inflammatory disease, mainly affecting the
gastrointestinal tract with extraintestinal manifestations and associated immune disorders …